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The paper presents 47 adult patients who were surgically treated due to brainstem gliomas.
Thirteen patients presentedwith contrast-enhancing Grades III and IV gliomas, according to
the WHO classiﬁcation, 13 patients with contrast-enhancing tumours originating from the
glial cells (Grade I; WHO classiﬁcation), 9 patients with diffuse gliomas, 5 patients with tectal
brainstem gliomas and 7 patients with exophytic brainstem gliomas. During the surgical
procedure, neuronavigation and the diffusion tensor tractography (DTI) of the corticospinal
tract were usedwith the examination ofmotor evoked potentials (MEPs) and somatosensory
evoked potentials (SSEPs) with direct stimulation of the fundus of the fourth brain ventricle
in order to deﬁne the localization of the nuclei of nerves VII, IX, X and XII. Cerebellar
dysfunction, damage to cranial nerves and dysphagia were themost frequent postoperative
sequelae which were also the most difﬁcult to resolve. The Karnofsky score established
preoperatively and the extent of tumour resection were the factors affecting the prognosis.
The mean time of progression-free survival (14 months) and the mean survival time after
surgery (20 months) were the shortest for malignant brainstem gliomas. In the group with
tectal brainstem gliomas, no cases of progression were found and none of the patients died
during the follow-up. Some patients were professionally active. Partial resection of diffuse
brainstem gliomas did not prolong themean survival above 5 years. However, some patients
survived over 5 years in good condition.
© 2018 Polish Neurological Society. Published by Elsevier Sp. z o.o. All rights reserved.1. IntroductionBrainstem gliomas account for only 1–2% of all adult gliomas
and are characterized by poor prognosis. In particular,* Corresponding author at: Katedra i Oddział Kliniczny Neurochirurgii
E-mail address: krzysztof.majchrzak@sum.edu.pl (K. Majchrzak).
https://doi.org/10.1016/j.pjnns.2018.08.008
0028-3843/© 2018 Polish Neurological Society. Published by Elsevier Sunfavourable prognosis is related to patients with enhancing
high-Grades III and IV gliomas (WHOclassiﬁcation) and diffuse
brainstem gliomas. However, in the latter group the prognosis
is better than in children [1–3]. A 5-year survival was reported
in 58% of adult patients with diffuse brainstem gliomas, which, Ul. Plac Medyków 1, 41-200 Sosnowiec, Poland.
p. z o.o. All rights reserved.
Table 1 – MRI-based radiological classification of
brainstem gliomas.
Cases
No %
1. Adult diffuse intrinsic low-grade brainstem gliomas 9 19
2. Contrast-enhancing malignant brainstem glioma 13 28
3. Contrast-enhancing non-malignant intrinsic glioma 13 28
4. Focal tectal brainstem gliomas 5 11
5. Exophytic brainstem gliomas 7 14
Total 47 100
n e u r o l o g i a i n e u r o c h i r u r g i a p o l s k a 5 2 ( 2 0 1 8 ) 6 2 3 – 6 3 3624is signiﬁcantly longer than in children [1–3]. Good prognosis is
expected after surgical intervention in patients with focal and
exophytic tumours [4–9].
Diagnosis of brainstem gliomaswas based on the character-
istic MRI features [7,8,10–13]. Another signiﬁcant factor is the
use of neuronavigation to determine tumour location and the
localization of the corticospinal tract within the neuronaviga-
tion system based on the diffusion tensor tractography (DTI)
examination. The use of corticospinal tract tractography
decreases the frequency of postoperative limb paresis [14].
Frequency of limb paresis is also decreased due to the
examination of motor evoked potentials (MEPs) with transcra-
nial electrical stimulation (TES) of the brain [14–16]. The direct
electrical stimulation (DES) of cerebral peduncles in tumours of
the ventral part of themidbrain or the pyramids of themedulla
oblongata enables us to ﬁnd the corticospinal tract. From the
practical point of view, it is vital to localize the nuclei of cranial
nerves VII, IX, X and XII on the basis of DES of the fundus of the
fourth brain ventricle during the surgical procedure [15].
The aim of the present study is the analysis of surgical
treatment results in adult patients with brainstem gliomas.
Attention was paid to the following questions:– what affects the prognosis of these patients;
– what are the beneﬁts of surgical treatment;
– what is the frequency of serious postoperative sequelae and
what is their tendency to resolve;– whether the prognosis depends on tumour location or
histological ﬁndings;– whether patients with diffuse brainstem gliomas should
undergo surgery;– what radiological and electrophysiological examinations
should be used during surgery to obtain the best surgical
outcome.– Experience of other surgeons in this respect is of great
importance. They presented surgical treatment results of
brainstem gliomas and discussed signiﬁcant prognostic
factors [2,7,8,14–17,20–24,26–28,30,32].2. Clinical material and methodsForty seven patients underwent surgery for brainstem gliomas
between 1998 and 2014. 26 of the patients were female and 21
were male (age range 18–74 years; mean age 38.7 years). The
follow-up period ranged from 3 months to 16 years (mean
follow-up 4.04 years). Table 1 presents surgically treated types
of brainstem glioma. The classiﬁcation was based on the
division presented by Botero [17] with some modiﬁcations by
the authors of this paper.
As it is shown in Table 1, patients with contrast-enhancing
malignant and non-malignant brainstem gliomas constituted
the largest group (n = 26). Nine patients presented with diffuse
brainstem gliomas, 7 patients with exophytic brainstem
gliomas and 5 patients with focal tectal brainstem gliomas.
Head MRI with PWI, DWI, DTI, 1 HMRS was performed. All
the surgical procedures were performed with the use of the
neuronavigation system, which was applied to determine
tumour location and the course of the corticospinal tract (DTItractography). In order to preserve the continuity of the
corticospinal tract, MEP recording obtained with transcranial
electrical stimulation (TES) was used. The localization of the
nuclei of nerves VII, IX, X and XII within the fundus of the
fourth ventricle was established by DES. Somatosensory
evoked potentials (SSEPs) were monitored.
The extent of resection was conﬁrmed by contrast-
enhanced MRI performed within one month after the surgical
procedure. The extent of resection was deﬁned either as a
gross total resection (when in the follow-up contrast MRI the
removal of over 80% of tumour mass was conﬁrmed) or as a
partial resection (resection of less than 80% of the baseline
tumour mass) [18]. The choice of the surgical approach was
determined by tumour location and the result of the course of
the corticospinal tract as measured by DTI.
The following surgical approacheswere used to remove the
brainstem lesions: suboccipital – 22 (47%); subtonsilar telovelar
– 8 (17%); far-lateral – 4 (6%); infratentorial, supracerebellar – 4
(6%); retrosigmoid – 4 (6%); temporal-posterior – 3 (5%);
subtemporal, transtentorial – 1 (4%); paramedian supracer-
ebellar – 1 (4%). The surgical approach related to surgical
treatment of brainstem gliomas was previously described in
our paper in 2005 [19].
After the surgical procedure, patients were transferred to
the Intensive Care Unit. Two outcome measures were
assessed: (1) progression-free survival (PFS), deﬁned as the
time from surgery to the increase in tumour size on follow-up
FLAIR imaging and/or demonstration of gadolinium enhance-
ment on follow-up imaging or malignant degeneration; (2)
overall survival (OS), deﬁned as the time between initial
surgery and death.
3. Methodology of statistical analysisStatistical analysis was performed using STATISTICA 10
software. Survival probability (OS, PFS) was calculated using
the Kaplan–Meier method. Differences between the courses of
the curves of the impact of the analyzed variables on survival
time (OS, PFS) were compared by the log-rank test and the
equivalent to the log-rank test for variables with many
categories (more than 2).4. Results
The following were the symptoms reported by patients on
admission to the Department of Neurosurgery: instability of
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headache – 15 (31%); visual disturbances – 12 (25%); limb
weakness – 12 (25%); vertigo – 10 (21%) and dysphagia – 8 (16%).
At 3 months postoperatively patients complained of gait
disturbances – 15 subjects (32%); diplopia – 10 (21%); sensory
disturbances – 9 (19%); visual disturbances – 8 (17%); headache
– 6 (13%); limb weakness – 6 (13%) and dysphagia – 4 (8%).
On admission, neurological examination revealed the
following neurological deﬁcits: gait disorders – 31 (66%);
decreased cerebellar function – 24 (51%); hemiparesis – 12
(25%) and cranial nerve palsy – 10 (21%).
Based on the presented data, on admission patientsmostly
complained of gait disorders, impairment of superﬁcial
sensation in the trunk and limbs, headache and vertigo.
Decreasedmuscular strength of the limbs and dysphagia were
frequently observed.
At 3months postoperatively, headache frequently resolved
and vertigo was less common. Dysphagia resolved and the
improvement in limb movement was observed.
In patients who underwent surgery for brainstem gliomas,
some new neurological deﬁcits were observed postoperatively
and some symptoms exacerbated compared to their preoper-
ative status. These complications are listed in Table 2. They
were compared with those during the last follow-up.
The most frequent postoperative sequelae were ataxia in
the lower or upper limbs and balance disorders (60%). These
disorders showed no tendency to resolve in comparison with
the last follow-up (55%). A relatively frequent postoperative
sequela was the damage to cranial nerves, in particular nerves
III, IV, VII, IX and X (40%). Postoperative dysfunction of the
cranial nerves did not show a tendency to resolve (45%).
However, in 2 patients we observed the resolution of eyelid
ptosis after brainstem surgery [14]. In 36% subjects, hemipar-
esis occurred. Moreover it showed a tendency to resolve over
time (19%). Dysphagia is a dangerous complication related to
surgical treatment of gliomas of the medulla oblongata (26%).
These patients required gastric tube feeding and intravenous
hydration. These symptoms resolved in half of the patients
(13%). Two patients failed to breathe spontaneously and, as a
result, were artiﬁcially ventilated for several weeks. In all
patients, spontaneous breathing returned. Also pulmonary
oedema, observed in 3 patients, resolved. Postoperative
mortality was 4.2%. Pulmonary embolism was the cause of
death of 1 patient despite antithrombotic treatment. Another
patient was in bad condition after the surgical procedure due
to cardiopulmonary insufﬁciency and died after 2 months.
Histological examination conﬁrmed the following types of
brain glioma: pilocytic astrocytoma – 17 (36.2); anaplastic
astrocytoma – 11 (23.4%); astrocytoma: ﬁbrillary, protoplasmic,
gemistocytic – 11 (23.4%); multiform glioblastoma – 2 (4.3%);Table 2 – Postoperative sequelae.
Imme
Decreased cerebellar function 28 (6
Cranial nerve palsy 19 (4
Hemiparesis 17 (3
Dysphagia 12 (2
Lack of spontaneous breathing 2 (4%
Neurogenic pulmonary oedema 3 (6%ependymoma – 3 (6.4%); oligodendroglioma – 1 (2.1%);
subependymoma – 1 (2.1%); ganglioglioma – 1 (2.1%).
The characteristics of patient groups is presented below.
4.1. Adult diffuse intrinsic low-grade brainstem gliomas
(n = 9)
Nine patients with diffuse brainstem gliomas underwent
surgery in accordance with the criteria speciﬁed by Botero
[17]. The majority of patients were below 40 years of age. The
pons was the most common tumour location (67%). Histolog-
ical assessment of all tumours conﬁrmed low-grade gliomas
(Grade II; WHO classiﬁcation). MRI examination revealed that
tumours did not enhance after contrast administration.
Tumour resection was partial in the majority of cases
(89%). Tumour progression deﬁned as an increase in tumour
volume was observed in 67% patients. According to the
Glasgow Outcome Scale, mortality was conﬁrmed in 4 (45%)
patients, severe disability in 3 (33%), whereas moderate
disability in 2 (23%).
4.2. Contrast-enhancing intrinsic malignant glioma
(n = 13)
Thirteen subjects with contrast-enhanced malignant brain-
stem gliomas underwent surgery. In the majority of cases,
patients were over 40 years of age (79%). Tumours were most
frequently located in the pons. Gross total resection was
performed in 15%, whereas in 85% of the patients partial
resection was done. Histological diagnosis revealed anaplastic
astrocytoma in 85% and multiform glioblastoma in 15% cases.
In the follow up period 8 (61%) of the patients died and
progression was observed in 9 (69%) subjects.
4.3. Contrast-enhancing non-malignant intrinsic glioma
(n = 13)
Thirteen patients presented with contrast-enhanced non-
malignant brainstem gliomas. These tumours were most
frequently located in the midbrain (38%) and in the medulla
oblongata (38%). Histological assessment most often revealed
pilocytic astrocytoma (92%). Gross total resection was per-
formed in 5 patients (38%), whereas partial resectionwas done
in 8 patients (62%). Four patients underwent revision surgery,
of whom3had delayed total resection. In the follow-up period,
3 patients died (23%), and progression was observed in 5
subjects (38%).
The case of a patient with pilocytic astrocytoma located in
the pons and the midbrain pre- and postoperatively is
presented below (Fig. 1).diate During the last follow-up
0%) 17/31 (55%)
0%) 14/31 (45%)
6%) 6/31 (19%)
6%) 4/31 (13%)
) 0
) 0
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Fig. 1 – (A and B) MRI of a patient with a tumour of the mesencephalon and the pons (sagittal section) before and after surgery.
Total tumour resection.
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Five patients with focal tectal midbrain gliomas underwent
surgery. These were only the cases with an increase in tumour
volume or the exacerbation of neurological deﬁcits in the
follow-up. Gross total resection was achieved in 60% cases.
After the surgery, the majority of patients were in good
condition (80%). No tumour progression was observed.
However, prognosis of a patient with malignant ependymoma
Grade III (WHO criteria) remains uncertain.
4.5. Exophytic brainstem gliomas (n = 7)
The patients over 40 constitute the majority of the group. In 6
subjects the tumour was located in the dorsal part and in 1
subject in the ventral part of the medulla oblongata. These
tumours enhanced after contrast administration. Total resec-
tion was performed in 4 patients (57%). Tumour progression
was observed only in 1 subject with anaplastic astrocytoma.
This patient died in less than 20 months after the diagnosis of
tumour progression. Other patients, even with partial tumour
resection, were in good condition or presented with some
discrete neurological deﬁcits such as deﬁcits of exteroception
and proprioception.
The case of a patient with exophytic brainstem tumour of
the anterior part of the medulla oblongata is presented in the
ﬁgure below (Fig. 2A and B). It is obligatory to use MEPs during
surgery because of the vicinity of the corticospinal tract with
the tumour.
The analysis of the correlation between the patient age and
prognosis was performed. No statistical signiﬁcance was
found. The Table 3 below illustrates this analysis.
Then the prognosis was assessed preoperatively, according
to the Karnofsky score (Table 4).
The Table 4 below illustrates this analysis.
The ﬁgure illustrating the above correlation is presented
below (Fig. 3)
There was a signiﬁcant difference in survival time among
patients with a different Karnofsky score assessed on the dayof admission (p < 0.05). Patients who had a higher score on
admission (i.e., 90 or 100) had the best prognosis.
Then the prognosis was established, depending on the
extent of resection (Table 5). The Table 5 illustrates this
analysis.
Patient prognosis depended signiﬁcantly on the extent of
tumour resection (p < 0.05). The majority of progression cases
occurred when partial tumour resection was done.
The Table 6 below illustrates the prognosis established
based on the Glasgow Outcome Scale depending on the
location and type of brainstem glioma. Due to a small number
of cases of midbrain tectal tumour and exophytic tumours,
these groups were analyzed together for the purposes of
statistical analysis (Table 6).
A statistically signiﬁcant correlation was observed between
the typeof thebrainstemtumour and the prognosis established
based on the Glasgow Outcome Scale (p < 0.05). The best
prognosis was observed in patients with tectal brainstem
tumours and exophytic tumours of the medulla oblongata.
The Table 7 below illustrates the prognosis established
based on the Glasgow Outcome Scale depending on the
histopathological investigation. Division of gliomas was done
according to theWHO classiﬁcation. Due to a small number of
cases Grade III and IV of gliomas were analyzed together for
the purposes of statistical analysis.
A statistically signiﬁcant correlation was observed between
the results of histopathological investigation and the progno-
sis established based on the GlasgowOutcome Scale (p < 0.05).
In the group of patients with pilocytic astrocytoma and
ganglioglioma, the patient condition was most commonly
diagnosed as GR + MD. The highest mortality was observed in
the group of patients with anaplastic astrocytoma and
glioblastoma multiforme.
Table 8 presents patients with postoperative progression.
A statistically signiﬁcant difference was observed between
various groups of patients with respect to PFS (p < 0.05).
Patients with tectal brainstem tumours had the highest
chances of PFS. The shortest mean time to progression was
observed in patients with malignant brainstem gliomas.
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Fig. 2 – (A) Preoperative MRI of a patient with an exophytic tumour of the pyramid of the medulla oblongata (frontal, sagittal
and axial sections). (B) Postoperative MRI. Subtotal tumour resection. The corticospinal tract was spared. The patient without
limb paresis. Histological investigation revealed pilocytic astrocytoma.
n e u r o l o g i a i n e u r o ch i r u r g i a p o l s k a 5 2 ( 2 0 1 8 ) 6 2 3 – 6 3 3 627
Table 3 – Death rate and age of the patients.
Patient's age Below 40 Over 40
Number of deaths 9 (56%) 7 (44%)
Number of subjects in observation 24 (51%) 23 (49%)
Table 4 – Survival of patients presenting on admission
with different score in Karnofsky performance scale.
Karnofsky score Mean survival period (months)
60 23
70 48
80 46
90 60
100 80
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Also a 5-year postoperative PFS was calculated and it was
48%, which means that fewer than half of all patients will
survive without progression (inmore than half of the patients,
the progression will occur within 5 years after brainstem
surgery).
Then the mean postoperative survival time was calculated
for patients who underwent surgery due to various types of
brainstem gliomas (Table 9).
A statistically signiﬁcant difference was observed between
various groups of patients in respect to the postoperative
survival period (p < 0.05). Patients with enhancing malignant
gliomas (anaplastic astrocytoma, glioblastoma multiforme)
had the worst prognosis. The best prognosis was observed in
patients with the tectal tumour (mesencephalic tectum).
Fig. 5 presents the graphic illustration of this correlation.
Also a 5-year survival after brainstem surgery was
calculated and was 76%, which means that the majority of
patients will survive at least 60 months postoperatively.
[(Fig._3)TD$FIG]
Fig. 3 – Kaplan–Meier graph of survival by score iThe quality of life of patients was assessed at 3 months
postoperatively. We considered independence of patients in
performing everyday activities. Asmuch as 68% of the patients
could run independent life. 40% of patients were in good
condition or presented withmoderate disability. At 12months
postoperatively, we examined whether any of the subjects
resumed employment. It was conﬁrmed in 4 of 12 patients
with tectal and exophytic gliomas.
5. DiscussionOn admission to the Neurosurgery Clinic, the major com-
plaints of surgical patients with brainstem gliomas were
related to gait disorders, impaired exteroception, visual
disturbances and headaches. These symptoms also occurred
in patients with brainstem tumours whose treatment was
discussed by other neurosurgeons [3,20–22]. The neurological
assessment of such patients revealedmost frequently balance
and gait disorders, limb ataxia, hemiparesis and the damage to
cranial nerves. We also observed the occurrence of alternating
neurological symptoms. Reyes–Botero pointed to similar
results of the neurological assessment of adult patients with
diffuse brainstem tumours [17].
Neurological condition of the patients used to deteriorate
after surgery. The worst symptoms included dysphagia,
neurogenic pulmonary oedema and lack of spontaneous
breathing. In 36% subjects, hemiparesis occurred. The last
two symptoms gradually resolved whereas dysphagia per-
sisted in 13% of patients. Hemiparesis which occurred after
operation in most of the patients resolved. We reported
resolution of hemiparesis in our subjects in the paper from
2005 [14].
Cerebellar symptoms and the damage to cranial nerves did
not show a tendency to resolve either. Mursch reported thatn the Karnofsky scale of initial performance.
Table 5 – Effect of the extent of resection on progression and survival.
Cases Progression Median PFS Median survival time
N N (%) Months
Gross Total resection 14 5(36%) 43 47
Partial resection 33 16(48%) 23 37
Table 6 – Glasgow Outcome Scale according to MRI-based radiological classification.
GR + MD SD DEATH Cases
1. Adult diffuse intrinsic low-grade brainstem gliomas 2 (22%) 3 (33%) 4 (45%) 9 (100%)
2. Contrast-enhancing malignant brainstem gliomas 1 (8%) 4 (31%) 8 (61%) 13 (100%)
3. Contrast-enhancing non-malignant gliomas 7 (54%) 3 (23%) 3 (23%) 13 (100%)
4. Focal tectal and exophytic brainstem gliomas 9 (75%) 2 (17%) 1 (8%) 12 (100%)
Cases in total 19 (40%) 12 (26%) 16 (34%) 47 (100%)
Table 7 – Glasgow Outcome Scale according to histopathological investigation.
GR + MD SD DEATH Cases
GI: pilocytic astrocytoma, ganglioglioma 11 (61%) 3 (20%) 4 (19%) 18 (100%)
GII: astrocytoma:ﬁbrillary,protoplasmic,gemistocytic, ependymoma,
oligodendroglioma, subependymoma
7 (46%) 5 (31%) 4 (23%) 16 (100%)
GIII + GIV: anaplastic astrocytoma, multiform glioblastoma 1 (7%) 4(31%) 8 (62%) 13 (100%)
Cases in total 19 (40%) 12 (26%) 16 (34%) 47 (100%)
Table 8 – The rates of progression among patients with different types of gliomas.
Tumour type Patients with progression Mean time of progression-free survival (months)
Adult diffuse brainstem glioma 6 (67%) 38
Malignant brainstem glioma 9 (69%) 14
Non-malignant brainstem glioma 5 (38%) 42
Exophytic tumour 1(14%) 13
Tectal tumour 0 –
n e u r o l o g i a i n e u r o ch i r u r g i a p o l s k a 5 2 ( 2 0 1 8 ) 6 2 3 – 6 3 3 629neurological deﬁcits exacerbated immediately after surgical
treatment of brainstem gliomas and showed a very small
tendency to resolve. In particular, this situationwas connected
with dysphagia and hemiparesis [23]. Sinha reported that after
surgery of brainstem tumours, postoperative complications
were observed in 19% of patients while the postoperative
mortality was 5% [22]. Other authors observed complications
immediately after surgery of brainstem gliomas in adult
patients in 51.6% subjects [24]. However, in a longer follow-up,
condition of patients improved and neurological deﬁcits
persisted only in 12.9% cases [24].
Authors report different extent of resection of brainstem
gliomas.We performed total resection in 14 patients (30%) and
partial resection in 33 patients (70%). The extent of resection in
our study had a signiﬁcant inﬂuence on patient survival.
Elhamady performed total or subtotal resection in 64% of
patients from a group of 31 adult subjects with brainstem
tumours [24]. Some other authors reported that they per-
formed total resection in patients with brainstem gliomas in
12.5%. This was related to patients with Grades I and II
astrocytoma (WHO classiﬁcation) and Grade II ependymoma.Subtotal resection was performed in 9 cases and partial in 3
cases [23]. According to the above authors, the following were
the causes of limited resection: arterial hypertension of 250–
300 mmHg or bradycardia (30–40 beats per minute), a decrease
in SSEPs observedduring surgery or no distinction between the
tumour and a healthy brainstem tissue [23]. Also in some of
our patients tumour resection could not be continued due to
incidents of hardly controllable hypertension approaching
300 mmHg. The disorders of SSEP recordings, as a rule, were of
transitory nature. AbnormalMEPs correlatedwith limb paresis
occurring postoperatively. The lack of a clear distinction
between the tumour and the healthy tissue in our study
material was related to intrinsic tumours, i.e., pilocytic
astrocytoma and Grade II astrocytoma (WHO scale).
Our results indicate that the prognosis is heavily inﬂuenced
by patient's performance on admission, as expressed by the
score in Karnofsky performance scale. A similar observation
was made by Kesari et al. [3]. Guillamo, in a group of adult
patientswith brainstem tumours, reported better prognoses in
patients, who had more than 70 points in the Karnofsky score
on admission [20].
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Fig. 4 – Kaplan–Meier graph of time to progression in different types of brainstem gliomas.
Table 9 – Survival after surgery in different types of brainstem gliomas.
Type of cancer Number of deaths Mean time period between the
surgical procedure and death (months)
Mean follow-up
period (months)
Adult diffuse brainstem glioma 4 (44%) 58 72
Malignant brainstem glioma 8 (62%) 20 32
Non-malignant brainstem glioma 3 (23%) 66 78
Exophytic tumour 1 (14%) 24 39
Tectal tumour 0 – 72
n e u r o l o g i a i n e u r o c h i r u r g i a p o l s k a 5 2 ( 2 0 1 8 ) 6 2 3 – 6 3 3630The international papers are dominated by a view of non-
resectability of low-grade diffuse brainstem gliomas in adult
patients, in particular when the tumour is located in the pons
[3,17]. Radiation is the proposed therapy and surgery is related
only to a biopsy or the elimination of the existing hydroceph-
alus [20,25–27]. Elhamady proposed surgical treatment of
[(Fig._5)TD$FIG]
Fig. 5 – Survival of patients with diffpatients with limited diffuse brainstem gliomas [24]. The
decision to perform surgery must be accompanied with an
effort to perform radical resection. This would mean a longer
period of patient survival. However, radical resections result in
neurological deﬁcits and lower quality of life. In our patients
with diffuse brainstem gliomas, partial resection of tumourserent types of brainstem glioma.
n e u r o l o g i a i n e u r o ch i r u r g i a p o l s k a 5 2 ( 2 0 1 8 ) 6 2 3 – 6 3 3 631was most often performed. However, partial resection of low-
grade gliomas in 9 patients did not prolong the mean survival
above 5 years. The studies conducted in Europe and in the
United States revealed the mean survival of patients with
diffuse brainstem gliomas who did not undergo surgery from
4.9 to 7.3 years [20,28]. In our study group, themean survival of
patients with diffuse brainstem gliomas was 4.8 years.
In our patients, the prevalence of malignant brainstem
gliomas was 28%. A similar prevalence (30%) of this type of
glioma in adult patients was reported by Duverneuil [29]. Most
frequently these tumours occurred in patients over 40 years of
age. This observation was conﬁrmed by other researchers who
observed an increased prevalence at older age [20,28]. These
types of tumours are characterized by a very short survival
period – the mean survival was about 12 months [3]. Other
studies report that overall mean survival time in patients
diagnosed with anaplastic astrocytoma and glioblastoma
multiforme was 25.8 months [30]. In our patients, the mean
survival was 20 months.
A large group of patients operated on for brainstem
tumours in our Neurosurgery Clinic consisted of subjects
with a histological diagnosis of pilocystic astrocytoma (cases
of intrinsic tumours). The majority of authors report good
prognosis of patients with total resection of this type of
tumour [22,31,32]. However, total resection was very difﬁcult
to perform due to the size of tumours. During the resection,
we observed disorders of heart rate abnormalities and the
decrease in SSEPs. Sometimes that was the reason why
surgical procedure was discontinued. This group of patients
also presented with abnormal respiratory rates. Therefore,
in 4 patients we performed delayed revision surgery after
the diagnosiswas obtained. Deterioration anddeath occurred
in patients with partial resection or in those who after
radical resection presented with severe disability. Ye J.M.
reported that the prognosis of patients with tumours of
pilocystic astrocytoma depends on tumour location. The
worst prognosis is related to patients with intrinsic pilocytic
astrocytoma. The prognosis in such cases depends on the
resection size [32].
In our studymaterial, the prevalence of themidbrain tectal
tumour was 11%. In other studies, the prevalence of this
tumour among brainstem tumours of adult patients was 8%
[17]. Patients with tectalmidbrain tumours underwent surgery
only in the case of an increase in neurological symptoms
caused by the tumour such as vision disorders or increasing
balance disorders. Surgical procedures were also performed in
patients in whom the size of the tumour was increased. In our
patients we did not observe any increase in hydrocephalus as
these tumours were growing exophytically upwards without
any pressure on the cerebral aqueduct. During the postopera-
tive follow-up we did not observe tumour progression and
none of our patients died. Tumours with this location
diagnosed in children offer good prognosis [33,34] and the
course of the disease is stable. In MRI examinations, these
tumours in children did not exceed 2 cm, neither did they
enhance after contrast administration [33]. In the majority of
children, it was necessary to treat hydrocephalus [34]. As in the
case of other surgeons, we also found such tumours as
pilocytic astrocytoma, ﬁbrillary astrocytoma and oligoastro-
cytoma in this location [20,35].Exophytic brainstem tumours are very rare among adult
patients [17,20,28]. This tumour most frequently arises
exophytically in the 4th brain ventricle [22]. In our subjects,
there were 6 cases of this tumour on the dorsal part and 1 case
on the ventral part of the medulla oblongata. In the case of
surgery of a tumour of the pyramid of themedulla oblongata, it
is necessary to use DES, which illustrates the relationship
between the tumour and the adjacent ﬁbres of the corticosp-
inal tract. Pilocytic astrocytoma was diagnosed in almost 50%
of cases. It must be borne in mind, however, that it is probable
that some malignant tumours enhancing after contrast
administration might also be found in this location, which
was observed in one case in our centre. In this patient,
anaplastic astrocytoma was diagnosed and after partial
resection, the tumour growth was observed, which resulted
in death of the patient at a further stage of the disease.
Considering all the cases, the progression of tectal
tumours and exophytic tumours was the longest. The most
rapid progression was observed in patients with Grades III
and IV gliomas as per WHO classiﬁcation. Kesari et al. made
similar observations [3]. The shortest survival period was
observed in patients with malignant brainstem tumours. A
5-year survival after brainstem surgery in our patients was
76%,whichmeans that themajority of patientswill survive at
least 60 months postoperatively. The mean follow-up was
4.04 years. Kesari, in a group of 101 patients with brainstem
gliomas observed a 5-year survival in 58%, and a 10-year
survival in 48% patients [3]. The mean survival was 3.9 years.
However, the majority of these patients were not surgical
subjects. Guillamo et al. observed a 3-year survival in 66%
cases in a group of 48 adult patients with brainstem gliomas
[20]. The mean follow-up was 5 years. In this group, 25%
patients were under surgical treatment (with the exception
of biopsy).
Mursch observed a 5-year survival in 25% of patients in a
group of 16 surgical patients with brainstem gliomas [23]. The
follow-up period was 6.7 years.
In conclusion, it should be stressed that brainstem glioma
patients in good condition should undergo surgery. Headache
and vertigo decrease postoperatively. In half of the patients
improvement in themovement of arms and legswas observed.
Dysphagia often resolved. Patients mainly complained of
dysfunction of the cerebellum and cranial nerve paresis. Good
recovery or moderate disability was noted in 40% of patients.
Some patients with exophytic tumour of mesencephalic
tectum and the dorsal part of the medulla oblongata were
professionally active.
6. Conclusions1. The prognosis of patients with brainstem gliomas was
affected by their general health condition as assessed on
hospital admission using the Karnofsky performance score
and by the extent of tumour resection.2. Among the symptoms less likely to resolve postoperatively
are cerebellar dysfunction and defects of cranial nerves.3. The best prognosis (as assessedwith the GlasgowOutcome
Scale) was observed in patients with tectal tumours
and exophytic tumours of the medulla oblongata and
n e u r o l o g i a i n e u r o c h i r u r g i a p o l s k a 5 2 ( 2 0 1 8 ) 6 2 3 – 6 3 3632in patients with gliomas–GI according to the WHO
classiﬁcation.4. Tumour progression and the highest mortality were
observed in patients with Grades III and IV gliomas (WHO
classiﬁcation).5. Reduction of tumour mass in patients with diffuse gliomas
fails to extend mean survival time beyond 5 years.6. Surgery of brainstem tumours adjacent to the corticospinal
tract requires the use of tractography aswell as transcranial
direct electrostimulation to elicit motor evoked potentials.Conﬂict of interestNone declared.
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